Frederick S. Vizeacoumar
Papers
1
Total Citations
15
H-Index
1
About
Frederick S. Vizeacoumar is a cancer biologist whose research focuses on functional genomics and high-throughput screening to identify therapeutic vulnerabilities in cancer, particularly head and neck squamous cell carcinoma (HNSCC). His major contributions include pioneering drug sensitivity testing across HPV-positive and HPV-negative HNSCC cell lines, revealing agents with preferential activity based on HPV status—a critical insight for precision oncology. This work, published in 2018 with 15 citations, demonstrates his impact in translating genomic data into actionable treatment strategies. Vizeacoumar’s expertise in large-scale genetic and chemical screens has advanced the understanding of how tumor heterogeneity influences drug response, directly informing clinical trial design. His collaborative approach, integrating bioinformatics and experimental validation, positions him as a key figure in the push toward personalized cancer therapy. By systematically mapping resistance and sensitivity patterns, his research continues to shape how clinicians select therapies for HNSCC patients, offering hope for more effective, subtype-specific interventions.
Research Focus
Key Achievements
Top Papers
- 1